鉴定gemcitabine作为一种抗拉萨病毒抑制剂使用一个强大的生物安全级别-2系统建模完整的病毒生命周期

Xiaoyou Hu1, Qian Guang1, Wenting Mao2

  • 1Infectious Disease Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Antiviral research
|February 25, 2026
PubMed
概括

研究人员开发了一种安全的拉萨病毒 (LASV) 逆转基因系统,以寻找新的治疗方法. 一种重新设计的药物gemcitabine对LASV表现出强烈的抗病毒活性,提供了一个有前途的治疗选择.